LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | BX-912 | 10 | uM | LJP5 | 2 | L19 | 72 | hr | 1209 | 1229 | 4252 | 0.2890 | 0.0088 |
MCF7 | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 1209 | 1152 | 4376 | 0.2633 | -0.0259 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 1209 | 3062 | 3823 | 0.8009 | 0.7497 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 1209 | 3160 | 4093 | 0.7719 | 0.7263 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 1209 | 3145 | 4121 | 0.7631 | 0.7165 |
MCF7 | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 1209 | 2672 | 3823 | 0.6989 | 0.6119 |
MCF7 | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 1209 | 2785 | 4093 | 0.6803 | 0.6066 |
MCF7 | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 1209 | 2855 | 4121 | 0.6928 | 0.6251 |
MCF7 | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 1209 | 2139 | 3823 | 0.5595 | 0.4097 |
MCF7 | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 1209 | 2732 | 4093 | 0.6673 | 0.5892 |
MCF7 | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 1209 | 2627 | 4121 | 0.6374 | 0.5504 |
MCF7 | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 1209 | 2374 | 3823 | 0.6210 | 0.5011 |
MCF7 | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 1209 | 2508 | 4093 | 0.6126 | 0.5137 |
MCF7 | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 1209 | 2671 | 4121 | 0.6481 | 0.5651 |
MCF7 | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 1209 | 2639 | 3823 | 0.6903 | 0.5998 |
MCF7 | Selumetinib | 3.33 | uM | LJP6 | 2 | M08 | 72 | hr | 1209 | 2778 | 4093 | 0.6786 | 0.6043 |
MCF7 | Selumetinib | 3.33 | uM | LJP6 | 3 | M08 | 72 | hr | 1209 | 2829 | 4121 | 0.6865 | 0.6168 |
MCF7 | Selumetinib | 10 | uM | LJP6 | 1 | M07 | 72 | hr | 1209 | 2579 | 3823 | 0.6746 | 0.5778 |
MCF7 | Selumetinib | 10 | uM | LJP6 | 2 | M07 | 72 | hr | 1209 | 2412 | 4093 | 0.5892 | 0.4805 |
MCF7 | Selumetinib | 10 | uM | LJP6 | 3 | M07 | 72 | hr | 1209 | 2577 | 4121 | 0.6253 | 0.5337 |
MCF7 | MK2206 | 0.04 | uM | LJP6 | 1 | F06 | 72 | hr | 1209 | 2396 | 3823 | 0.6267 | 0.5094 |
MCF7 | MK2206 | 0.04 | uM | LJP6 | 2 | F06 | 72 | hr | 1209 | 2250 | 4093 | 0.5496 | 0.4231 |
MCF7 | MK2206 | 0.04 | uM | LJP6 | 3 | F06 | 72 | hr | 1209 | 2629 | 4121 | 0.6379 | 0.5511 |
MCF7 | MK2206 | 0.12 | uM | LJP6 | 1 | F05 | 72 | hr | 1209 | 2265 | 3823 | 0.5925 | 0.4592 |
MCF7 | MK2206 | 0.12 | uM | LJP6 | 2 | F05 | 72 | hr | 1209 | 2394 | 4093 | 0.5848 | 0.4742 |